Stay updated on AD Up Clinical Trial
Sign up to get notified when there's something new on the AD Up Clinical Trial page.

Latest updates to the AD Up Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page header; this is a minor metadata change and does not affect the study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRecruitment status changed from Enrolling by invitation to Active, not recruiting. Enrollment updated from Estimated 1500 to Actual 1533 with the latest update posted on 2025-12-23.SummaryDifference0.1%

- Check34 days agoChange DetectedAdded a comprehensive, country/region–organized list of study locations worldwide (spanning US states, Australia regions, European regions, and other countries) and removed the previous consolidated location groupings.SummaryDifference3%

- Check48 days agoChange DetectedAdded a 2025 publication reference for the Upadacitinib AD trial (Irvine et al., Am J Clin Dermatol 2025) in the Publications section. Removed the previous Online ahead of print citation for the same article.SummaryDifference0.0%

- Check55 days agoChange DetectedThe change adds Revision: v3.3.2 and removes Revision: v3.3.1. This is a minor metadata update that does not alter study details or eligibility criteria.SummaryDifference0.0%

- Check62 days agoChange DetectedPublications are automatically filled from PubMed and may not all pertain to the study; revision number updated to v3.3.1.SummaryDifference0.0%

Stay in the know with updates to AD Up Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AD Up Clinical Trial page.